Anika Therapeutics Inc (ANIK)

Cost of Revenue

$45.65M

TTM · Period ending: · USD

ANIK logo

ANIK Cost of Revenue

Latest reported$45.65M
ANIK TTM Cost of Revenue ($3.50M → $45.65M)
High-resolution chart · PNG

ANIK cost of revenue history

Trailing twelve months (TTM) · USD. Each value covers four complete reported quarters.

Anika Therapeutics Inc Cost of Revenue — Trailing twelve months (TTM) (USD)
Period endingCost of Revenue (USD)
45,650,000
48,140,000
49,012,000
13,721,000
38,801,000
35,180,000
39,588,000
80,085,000
59,293,000
64,388,000
63,574,000
62,423,000
63,387,000
62,852,000
62,660,000
64,856,000
63,884,000
66,422,000
64,851,000
63,108,000
60,946,000
60,549,000
61,431,000
54,136,000
45,736,000
35,636,000
28,747,000
27,099,000
29,430,000
30,746,000
31,280,000
32,995,000
30,963,000
29,126,000
27,364,000
26,187,000
24,935,000
24,685,000
24,027,000
22,778,000
22,955,723
22,164,782
21,053,222
20,274,808
20,823,885
20,882,739
20,930,318
21,654,066
21,306,834
22,285,253
22,765,404
23,799,956
25,643,416
27,416,310
28,988,621
28,847,185
29,021,079
27,592,657
26,783,738
26,357,962
25,071,542
24,307,490
23,826,603
20,736,957
18,179,829
15,582,237
13,670,228
12,880,130
12,833,742
13,184,112
13,188,516
13,591,565
13,224,886
12,604,137
11,880,989
11,709,121
10,695,842
10,562,965
11,117,861
10,329,750
11,971,722
11,197,818
11,144,000
11,213,000
9,897,000
10,222,000
9,949,000
9,874,000
9,353,000
8,757,000
8,005,000
7,433,446
7,634,963
7,990,281
8,108,695
8,017,421
8,439,486
8,347,217
8,004,489
9,513,020
Data is provided for informational purposes only and does not constitute investment advice. Past performance is not indicative of future results.